UNSPSC 41141952: Cystine test system

In this classification, Cystine test system connotes a device used to measure Cystine levels. US FDA regulates Cystine test system under 21 CFR 862.1240 and under FDA product code JLD.

UNSPSC 41141952 Cystine test system is a Commodity code under which state and local governments procure laboratory testing reagents, kits, and reference materials for forensic drug analysis, toxicology screening, and disease surveillance in public health and law enforcement laboratories. The recent solicitation activity shows procurement of Direct ELISA testing kits for substance analysis (cannabinoids, opiates, PCP, amphetamines, and related compounds), certified drug reference standards for method validation and evidentiary sample analysis, and specialized diagnostic test equipment such as the RAMP System for mosquito-borne disease detection (West Nile Virus, Dengue). State and local issuing bodies under this code include state departments of public safety and criminal justice, state health and human services agencies, county forensic laboratories, and state environmental or public health divisions. The mix reflects demand from both law enforcement and public health branches within state government.

Geographic activity centers on Texas and Florida, with recent opportunities posted by the Texas Department of Public Safety, Texas Health and Human Services Commission, and Pinellas County Forensic Laboratory in Florida, alongside interstate cooperative purchasing through the Illinois Department of Financial and Professional Regulation. Representative recent solicitations include the Texas Department of Public Safety's IFB 40526R0008445A (posted July 9, 2026, due July 23, 2026) for Direct ELISA testing kits for cannabinoids, opiates, PCP, and other controlled substances; Pinellas County's Invitation to Quote 26-0305-ITQ (posted April 23, 2026) for certified drug reference standards meeting ISO 17025 accreditation standards, funded through a $72,126.85 Paul Coverdell Forensic Sciences Improvement Act grant; and the Texas Health and Human Services Commission's IFB HHS0016902v2 (due January 29, 2026) for QIAxcel and QIAamp DNA screening kits for state laboratory DNA analysis, with estimated historical spend of $25,050 to $30,000 in fiscal 2025. The Pinellas County procurement included a five percent price preference for Certified Small Business Enterprises submitting within the first five business days of the quote period.